LAMOND CAPITAL PARTNERS LLC Information

50 CALIFORNIA STREET, SUITE 1330, SAN FRANCISCO, California, 94111, (415) 848-2260

Report Date: 12/31/2015

Position Statistics

Total Positions 12
New Positions 6
Increased Positions 6
Decreased Positions 6
Positions with Activity 12
Sold Out Positions 5
Total Mkt Value (in $ millions) 58

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 65.1%
Services
Technology 34.34%
Transportation
Utilities

12 Positions as of 12/31/2015

Company ▲ Class Value of Shares ($1,000s) Change in Value ($1,000s) Change (%) Shares Held
ABBVIE INC COM 18,300 18,300 New 300,000
ALEXION PHARMACEUTICALS INC COM -13,928 Sold Out 0
AMGEN INC COM 11,873 -3,958 (25) 75,000
BIOMARIN PHARMACEUTICAL INC COM -8,468 Sold Out 0
CYPRESS SEMICONDUCTOR CORP COM -9,933 Sold Out 0
GW PHARMACEUTICALS PLC ADS -9,722 Sold Out 0
IGNYTA INC COM 323 323 New 46,721
IMMUNOMEDICS INC COM 355 355 New 100,000
OCULAR THERAPEUTIX INC COM -15,145 Sold Out 0
ORACLE CORP COM 19,930 19,930 New 500,000
PUMA BIOTECHNOLOGY INC COM 6,776 6,776 New 220,780
ZELTIQ AESTHETICS INC COM 482 482 New 16,119